Affymetrix Up on Upbeat Rev Guidance

08-01-2014 Zacks.comComments (0)

AffymetrixPharmaceutical

Affymetrix expects fourth quarter 2013 revenues around $91 million, representing an increase of 7.8% from $84.4 million in the year-ago quarter. Affymetrix' fourth quarter revenue guidance includes a one-time licensing payment of $5.3 million from one ...

Read more on Zacks.com

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top